{"nct_id":"NCT01231594","title":"A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2010-11-05","start_date_type":"ACTUAL","primary_completion_date":"2018-04-09","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}